BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13015384)

  • 21. The prognostic value of histaminase and pregnandiol determination in threatening abortion.
    BORGLIN NE; WILLERT B
    Acta Obstet Gynecol Scand; 1957; 36(3):382-97. PubMed ID: 13469310
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progesterone therapy in threatened abortion].
    BORTH R; DE WATTEVILLE H
    Med Hyg (Geneve); 1952 Aug; 10(223):316. PubMed ID: 13001380
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progesterone in large doses: metabolic and therapeutic aspects].
    Montanino G; Vizzone A
    Minerva Ginecol; 1966 Aug; 18(16):880-4. PubMed ID: 5989252
    [No Abstract]   [Full Text] [Related]  

  • 24. Pregnanediol excretion in cases of habitual abortion.
    SWYER GI
    J Endocrinol; 1953 Jan; 9(1):Suppl ii. PubMed ID: 14509609
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of high doses of progesterone and diethylstilbestrol in the treatment of threatened abortions].
    CASTELAZO AYALA L
    Obstet Ginecol Lat Am; 1953 Jun; 11(6):195-204. PubMed ID: 13099739
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dynamic studies on pregnandiol in urine as a method of control of the treatment of spontaneous abortion].
    ZAKHAROVA VA
    Akush Ginekol (Mosk); 1953; 3():26-9. PubMed ID: 13080098
    [No Abstract]   [Full Text] [Related]  

  • 27. [Microcrystalline suspension of estrogens and progesterone in therapy of threatened abortion].
    ANDREOLI C
    Minerva Ginecol; 1955 Sep; 7(18):214-7. PubMed ID: 13287952
    [No Abstract]   [Full Text] [Related]  

  • 28. [Associated hormone therapy (estrogens-progesterone) of threatened abortion].
    CARBONINI M
    Ann Ostet Ginecol; 1951 Oct; 73(10):1319-41. PubMed ID: 14915337
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of urinary estrogen pregnanediol and pregnanetriol in threatened abortion].
    Koda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 May; 20(5):505-12. PubMed ID: 5693367
    [No Abstract]   [Full Text] [Related]  

  • 30. [About the clinical value of estimations of plasma progesterone levels and urinary pregnandiol output in cases of imminent abortion during the first half of pregnancy (author's transl)].
    Misinger I; Sorfová J; Mares J; Soukup K; Papez L; Srp B
    Cesk Gynekol; 1981 Nov; 46(9):668-72. PubMed ID: 7307118
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vaginal cytology and urinary pregnanediol levels in threatened abortion, actual abortion and missed abortion].
    Pannain A
    Arch Ostet Ginecol; 1969; 74(1):14-49. PubMed ID: 5404584
    [No Abstract]   [Full Text] [Related]  

  • 32. Pregnandiol excretion and corpus luteum therapy in habitual abortion.
    ALDER R
    Fertil Steril; 1953; 4(2):170-2. PubMed ID: 13033957
    [No Abstract]   [Full Text] [Related]  

  • 33. [Abortions in endocrine disorders; on the question of the clinical importance of quantitative determinations of pregnandiol in urine].
    DIBBELT L
    Med Klin; 1952 Dec; 47(51):1707-8. PubMed ID: 13024713
    [No Abstract]   [Full Text] [Related]  

  • 34. The value of the pregnanediol excretion test in the prognosis of abortion.
    RAWLINGS WJ; KRIEGER VI
    J Obstet Gynaecol Br Emp; 1959 Dec; 66():905-13. PubMed ID: 14436593
    [No Abstract]   [Full Text] [Related]  

  • 35. Sodium pregnandiol glucuronidate determinations in threatened abortion.
    YANOW M; SOULE SD; MEYERHARDT MH
    Am J Obstet Gynecol; 1950 May; 59(5):1160-3. PubMed ID: 15410838
    [No Abstract]   [Full Text] [Related]  

  • 36. A clinical trial and cytological assessment of enol LUTEOVIS IN THE TREATMENT OF THREATENED AND RECURRENT ABORTION.
    Burton ER; Wachtel EG
    J Obstet Gynaecol Br Commonw; 1967 Aug; 74(4):533-6. PubMed ID: 5340429
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance of vaginal hormone cytology and pregnanediol excretion in the urine for the prognosis of imminent abortion].
    TIMONEN S; GOELTNER E
    Zentralbl Gynakol; 1959 Aug; 81():1263-71. PubMed ID: 13838451
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations on the use of progesterone in threatened abortion with special reference to pregnandiol excretion as a guide to therapy.
    GUTERMAN HS; TULSKY AS
    Am J Obstet Gynecol; 1949 Sep; 58(3):495-502. PubMed ID: 18137073
    [No Abstract]   [Full Text] [Related]  

  • 39. Implications of pregnanediol titre pattern on the fate of threatened abortion.
    Ghosh RN
    J Indian Med Assoc; 1976 Jan; 66(1):4-6. PubMed ID: 1270821
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnandiol excretion in women.
    FURUHJELM M
    Acta Endocrinol (Copenh); 1953 Dec; 14(4):353-60. PubMed ID: 13137847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.